T. Rowe Price Associates
FRTX

T. Rowe Price Associates’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

T. Rowe Price Associates’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,488
Closed -$14.7M – 2479
2013
Q2 		$14.7M Buy
+1,488
New +$14.7M ﹤0.01% 1157